A Pertzelan

3.1k total citations
82 papers, 2.3k citations indexed

About

A Pertzelan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, A Pertzelan has authored 82 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in A Pertzelan's work include Growth Hormone and Insulin-like Growth Factors (44 papers), Sexual Differentiation and Disorders (25 papers) and Pituitary Gland Disorders and Treatments (11 papers). A Pertzelan is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (44 papers), Sexual Differentiation and Disorders (25 papers) and Pituitary Gland Disorders and Treatments (11 papers). A Pertzelan collaborates with scholars based in Israel, United States and Australia. A Pertzelan's co-authors include Zvi Laron, Zvi Laron, Liora Lazar, Rivka Kauli, S. Mannheimer, M Karp, Moshe Phillip, William H. Daughaday, Ζ. Josefsberg and Avinoam Galatzer and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Annals of the New York Academy of Sciences.

In The Last Decade

A Pertzelan

79 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Pertzelan Israel 25 1.7k 774 670 368 301 82 2.3k
Thomas P. Foley United States 29 1.6k 1.0× 655 0.8× 502 0.7× 221 0.6× 498 1.7× 85 2.8k
M Vanderschueren‐Lodeweyckx Belgium 27 1.0k 0.6× 811 1.0× 505 0.8× 186 0.5× 454 1.5× 92 2.0k
S. Douglas Frasier United States 26 1.2k 0.7× 897 1.2× 625 0.9× 295 0.8× 441 1.5× 80 2.3k
Solomon A. Kaplan United States 28 1.1k 0.6× 577 0.7× 330 0.5× 182 0.5× 344 1.1× 79 2.3k
U. Heinrich Germany 26 1.3k 0.8× 1.2k 1.6× 1.2k 1.7× 143 0.4× 461 1.5× 70 2.8k
Catherine Dacou‐Voutetakis Greece 27 1.1k 0.7× 759 1.0× 603 0.9× 295 0.8× 299 1.0× 99 2.1k
Nancy J. Hopwood United States 20 1.1k 0.7× 535 0.7× 265 0.4× 296 0.8× 154 0.5× 45 1.7k
G Baumann United States 22 1.1k 0.6× 460 0.6× 260 0.4× 389 1.1× 154 0.5× 51 1.8k
P Malvaux Belgium 23 970 0.6× 708 0.9× 439 0.7× 208 0.6× 360 1.2× 77 1.7k
Claudine Heinrichs Belgium 30 1.1k 0.7× 1.1k 1.4× 907 1.4× 288 0.8× 614 2.0× 88 2.6k

Countries citing papers authored by A Pertzelan

Since Specialization
Citations

This map shows the geographic impact of A Pertzelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Pertzelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Pertzelan more than expected).

Fields of papers citing papers by A Pertzelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Pertzelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Pertzelan. The network helps show where A Pertzelan may publish in the future.

Co-authorship network of co-authors of A Pertzelan

This figure shows the co-authorship network connecting the top 25 collaborators of A Pertzelan. A scholar is included among the top collaborators of A Pertzelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Pertzelan. A Pertzelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lazar, Liora, Uri Pollak, Ofra Kalter‐Leibovici, A Pertzelan, & Moshe Phillip. (2003). Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA). European Journal of Endocrinology. 149(5). 425–432. 65 indexed citations
3.
Lazar, Liora, et al.. (2003). PROP-1 Gene Mutation (R120C) Causing Combined Pituitary Hormone Deficiencies with Variable Clinical Course in Eight Siblings of One Jewish Moroccan Family. Hormone Research in Paediatrics. 60(5). 227–231. 17 indexed citations
4.
Weintrob, Naomi, et al.. (2000). Combined clonidine-short-ACTH test for the simultaneous assessment of growth hormone reserve and hypothalamic-pituitary-adrenal axis integrity in children. European Journal of Endocrinology. 143(1). 105–110. 3 indexed citations
5.
Brautbar, Chaim, A Pertzelan, Ζ. Josefsberg, et al.. (2000). Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. European Journal of Endocrinology. 143(3). 397–403. 50 indexed citations
6.
Kornreich, Liora, Gadi Horev, Liora Lazar, Ζ. Josefsberg, & A Pertzelan. (1997). MR findings in hereditary isolated growth hormone deficiency.. American Journal of Neuroradiology. 18(9). 1743–1747. 16 indexed citations
7.
Keret, R, et al.. (1996). Two Types of Growth Hormone Rhythm in Boys with Constitutional Short Stature. Journal of Pediatric Endocrinology and Metabolism. 9(6). 599–607. 2 indexed citations
8.
Cohen, A, et al.. (1995). Final height of girls with Turner's syndrome: correlation with karyotype and parental height. Acta Paediatrica. 84(5). 550–554. 13 indexed citations
9.
Laron, Zvi, Anne‐Maria Suikkari, B. Klinger, et al.. (1992). Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature. European Journal of Endocrinology. 127(4). 351–358. 19 indexed citations
11.
Shuper, Avinoam, et al.. (1987). Familial Hashimoto's thyroiditis with kidney impairment.. Archives of Disease in Childhood. 62(8). 811–814. 8 indexed citations
12.
Danziger, Y, A Pertzelan, & Marc Mimouni. (1987). Transient congenital hypothyroidism after topical iodine in pregnancy and lactation.. Archives of Disease in Childhood. 62(3). 295–296. 25 indexed citations
14.
Kauli, Rivka, et al.. (1984). TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE. Clinical Endocrinology. 20(4). 377–387. 31 indexed citations
15.
Pertzelan, A, et al.. (1979). LINEAR GROWTH IN HYPOPITUITARY PATIENTS TREATED WITH hGH AFTER AGE FIFTEEN. Acta Paediatrica. 68(S277). 69–74. 6 indexed citations
16.
Pertzelan, A, Rivka Kauli, S. Assa, Dan Greenberg, & Zvi Laron. (1976). INTERMITTENT TREATMENT WITH HUMAN GROWTH HORMONE (GH) IN ISOLATED GH DEFICIENCY AND IN MULTIPLE PITUITARY HORMONE DEFICIENCIES. Clinical Endocrinology. 5(1). 15–24. 2 indexed citations
17.
Josefsberg, Ζ., et al.. (1976). Comparative HGH response to i.v. glucagon and i.v. arginine stimulation tests in children and adolescents. European Journal of Pediatrics. 121(2). 149–154. 4 indexed citations
18.
Laron, Zvi, et al.. (1970). ACTH Deficiency in Children and Adolescents (Clinical and Psychological Aspects). Progress in brain research. 32. 305–315. 1 indexed citations
20.
Laron, Zvi, A Pertzelan, & S. Mannheimer. (1966). Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?. PubMed. 2(2). 152–5. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026